Donald W. DeGolyer - Oct 3, 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Jennifer Lynn Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Oct 3, 2023
Transactions value $
$0
Form type
4
Date filed
10/5/2023, 07:08 PM
Previous filing
Oct 5, 2023
Next filing
May 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Award $0 +119K $0.00 119K Oct 3, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. These restricted stock units will vest in three equal installments over a three-year period assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.